Patents-Review.com
ClassID:

110979 ⎘

C12N2760/18523 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Pneumovirus, e.g. human respiratory syncytial virus Virus like particles [VLP]

Recent Application in this class:
#1
20260137767
2026-05-21

LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES

 #2
20260117202
2026-04-30

MUTANT OF RSV F PROTEIN

 #3
20260007740
2026-01-08

VACCINE COMPOSITION

 #4
20250388627
2025-12-25

PREFUSION RSV F PROTEINS AND THEIR USE

 #5
20250161436
2025-05-22

MULTIVALENT VACCINE FOR PARAMYXOVIRUSES AND USES THEREOF

 #6
20240350616
2024-10-24

VIRUS-LIKE PARTICLE VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS

 #7
20240209032
2024-06-27

Prefusion RSV F proteins and their use

 #8
20230293667
2023-09-21

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

 #9
20230086093
2023-03-23

MUTANT RSV F PROTEIN AND USE THEREOF

 #10
20220064222
2022-03-03

Prefusion RSV F proteins and their use

 #11
20220054619
2022-02-24

LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES

 #12
20210128717
2021-05-06

VACCINE COMPOSITION

 #13
20200299335
2020-09-24

Recombinant RSV G proteins and their use

 #14
20200030436
2020-01-30

Modified RSV F proteins and methods of their use

 #15
20190330277
2019-10-31

Recombinant prefusion RSV F proteins and uses thereof

 #16
20190134187
2019-05-09

Modified RSV F proteins and methods of their use

 #17
20190112340
2019-04-18

Substitutions-modified prefusion RSV F proteins and their use

 #18
20190030156
2019-01-31

Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine

 #19
20180320146
2018-11-08

Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

 #20
20180318411
2018-11-08

Method of vaccination with an attenuated RSV vaccine formulation

 #21
20170189523
2017-07-06

Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby

 #22
20170095550
2017-04-06

Immunogenic respiratory syncytial virus glycoprotein-containing VLPs and related compositions, constructs, and therapeutic methods

 #23
20150359872
2015-12-17

Modified RSV F proteins and methods of their use

 #24
20150266930
2015-09-24

Modified RSV F proteins and methods of their use

 #25
20150265698
2015-09-24

Modified RSV F proteins and methods of their use

 #26
20150050306
2015-02-19

Epitope-scaffold immunogens against respiratory syncytial virus (RSV)

 #27
20140294879
2014-10-02

Modified RSV F proteins and methods of their use

 #28
20140255441
2014-09-11

VLPS containing ligands and methods related thereto

 #29
20140134203
2014-05-15

Respiratory syncytial virus (RSV) sequences for protein expression and vaccines

 #30
20120093855
2012-04-19

RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF

 #31
20110236408
2011-09-29

Respiratory synctial virus (RSV) sequences for protein expression and vaccines

 #32
20110097358
2011-04-28

RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)

 #33
20110097355
2011-04-28

Virus-like particles as vaccines for paramyxovirus

 #34
20100239617
2010-09-23

Modified RSV F proteins and methods of their use

 #35
20100184192
2010-07-22

Avian influenza chimeric VLPS

 #36
20090263420
2009-10-22

Virus-like particles as vaccines for paramyxovirus

 #37
20090068221
2009-03-12

Virus-like particles as vaccines for paramyxovirus

 #38
20080233150
2008-09-25

RESPIRATORY SYNCYTIAL VIRUS-VIRUS LIKE PARTICLE (VLPS)

 #39
20070225227
2007-09-27

Lipoparticles comprising ion channels, methods of making and using the same

 #40
20070178120
2007-08-02

Virus-like particles as vaccines for paramyxovirus